Small Molecule Development and Clinical Manufacturing

Breaking news and analysis on small molecule drug development and clinical manufacturing — from early research and formulation through to regulatory submission.

Brought to you by:
Antares and Rho Ophiuchi cloud complex in the Sagittarius constellation
Biotech

Novartis pays Antares $105M to tackle undruggable cancer targets

Novartis is paying Antares $105 million upfront in a deal worth up to $1.9 billion to tackle historically undruggable cancer targets.
Nick Paul Taylor Jun 24, 2026 9:13am
A graphic symbolizing one group acquiring another

Biogen inks $1B RayThera buyout to bag immunology assets

Jun 18, 2026 4:10am
weight loss GLP-1

Ambrosia scores $100M series B to advance next-gen oral GLP-1

Mar 31, 2026 10:02am
Various shades of blue sewing thread spools

Amgen weaves in UK biotech with up to $840M acquisition

Jan 6, 2026 10:35am
person throwing away garbage or recycling

After $4.8B Amicus buy, BioMarin drops genetic disease asset

Dec 22, 2025 11:12am
sailing boat water yacht ocean wind

Voyager sets sail on neuro research trek with Transition Bio

Nov 10, 2025 5:23pm